| Literature DB >> 35757328 |
Hongyuan Lin1, Yi Chang1, Hongwei Guo1, Xiangyang Qian1, Xiaogang Sun1, Cuntao Yu1.
Abstract
Objective: To develop and validate a nomogram model to predict postoperative 30-day mortality in acute type A aortic dissection patients receiving total aortic arch replacement with frozen elephant trunk technique. Method: Clinical data on 1,156 consecutive acute type A aortic dissection patients who got total aortic arch replacement using the frozen elephant trunk technique was collected from January 2010 to December 2020. These patients were divided into training and testing cohorts at random with a ratio of 7:3. To predict postoperative 30-day mortality, a nomogram was established in the training set using the logistic regression model. The novel nomogram was then validated in the testing set. The nomogram's calibration and discrimination were evaluated. In addition, we created four machine learning prediction models in the training set. In terms of calibration and discrimination, the nomogram was compared to these machine learning models in testing set.Entities:
Keywords: FET; aortic dissection (AD); machine learning (ML); nomogram; prediction model; surgery
Year: 2022 PMID: 35757328 PMCID: PMC9226415 DOI: 10.3389/fcvm.2022.905908
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Flow chart of patient enrollment.
Figure 2Nomogram prediction model of 30-day mortality in acute aortic dissection patients undergoing total arch replacement surgery.
Patient demographics and clinical features.
|
|
|
|
|
|---|---|---|---|
|
| |||
| Age, mean ± SD | 46.95 ± 9.92 | 46.90 ± 10.27 | 0.939 |
| Female, | 160 (19.9) | 73 (20.9) | 0.755 |
| BMI, mean ± SD | 26.36 ± 4.21 | 26.12 ± 5.10 | 0.4 |
| Marfan syndrome, | 60 (7.4) | 30 (8.6) | 0.591 |
| Diabetes mellitus, | 23 (2.9) | 4 (1.1) | 0.119 |
| Previous stroke, | 33 (4.1) | 13 (3.7) | 0.889 |
| Chronic kidney disease, | 5 (0.6) | 4 (1.1) | 0.572 |
| COPD, | 2 (0.2) | 2 (0.6) | 0.753 |
| ALT (unit/L), mean ± SD | 30.87 ± 36.86 | 40.30 ± 12.78 | 0.224 |
| EGFR (ml/min/1.73m2), mean ± SD | 101.35 ± 38.21 | 99.48 ± 34.64 | 0.432 |
| EGFR <50 ml/min/1.73m2, | 45 (5.6) | 19 (5.4) | 1 |
| NYHA III or IV, n(%) | 166 (20.6) | 85 (24.3) | 0.187 |
| Hypertension, n(%) | 520 (64.5) | 224 (64.0) | 0.919 |
| Coronary artery disease, | 58 (7.2) | 23 (6.6) | 0.797 |
| Atrial fibrillation, | 8 (1.0) | 3 (0.9) | 1 |
| Previous cardiovascular surgery, | 20 (2.5) | 8 (2.3) | 1 |
| Previous TEVAR, | 12 (1.5) | 3 (0.9) | 0.556 |
| Instable hemodynamics, | 35 (4.3) | 23 (6.6) | 0.147 |
|
| |||
| LVEDD <45 mm, | 90 (11.2) | 47 (13.4) | 0.32 |
| Ejection fraction, | 60.35 (4.31) | 60.04 (4.63) | 0.276 |
| Severe aortic regurgitation, | 81 (10.0) | 50 (14.3) | 0.051 |
| Hydropericardium, | 11 (1.4) | 5 (1.4) | 1 |
|
| |||
| Severely compressed true lumenin descending aorta, | 78 (9.7) | 29 (8.3) | 0.522 |
| Persistent abdominal pain, | 9 (1.1) | 5 (1.4) | 0.878 |
| Lower limb ischemia, | 54 (6.7) | 18 (5.1) | 0.382 |
| Clinical coronary ostium involved, | 116 (14.4) | 50 (14.3) | 1 |
| Carotid ostium involved | 478 (59.3) | 205 (58.6) | 0.867 |
| Radiological Celiac trunk malperfusion, | 74 (9.2) | 37 (10.6) | 0.53 |
| Radiological superior mesenteric artery malperfusion, | 56 (6.9) | 32 (9.1) | 0.241 |
| Renal malperfusion, | 40 (5.0) | 28 (8.0) | 0.06 |
| Radiological iliac-femoralmalperfusion, n(%) | 82 (10.2) | 37 (10.6) | 0.921 |
|
| |||
| Concomitant with aortic root surgery, | 216 (26.8) | 108 (30.9) | 0.18 |
| CABG, | 104 (12.9) | 42 (12.0) | 0.743 |
| Salvage CABG, | 14 (1.7) | 8 (2.3) | 0.694 |
| Carotid bypass, | 30 (3.7) | 5 (1.4) | 0.057 |
| CPB time > 4 h, | 146 (18.1) | 58 (16.6) | 0.584 |
| DHCA temperature (degree centigrade), mean ± SD | 22.04 ± 3.58 | 21.74 ± 3.39 | 0.179 |
| DHCA time (minutes), mean ± SD | 18.57 ± 6.90 | 19.37 ± 6.59 | 0.067 |
|
| |||
| 30-day postoperative deaths, | 43 (5.3) | 27 (7.7) | 0.154 |
SD, standard deviation; BMI, body mass index; COPD, chronic obstructive pulmonary disease; ALT, Alanine Aminotransferase; EGFR, estimated glomerular filtration rate; NYHA, New York heart association; TEVAR, thoracic endovascular aortic repair; TTE, transthoracic echocardiography; LVEDD, left ventricular end-diastolic diameter; CTA, computed tomographic angiography; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; DHCA, deep hypothermia and circulatory arrest.
Definitions of risk factors.
|
|
|
|---|---|
| Age | - |
| Female | - |
| BMI | Body mass index |
| Marfan syndrome | Documented past history or fulfilled the revised Ghent criteria |
| Diabetes mellitus | Documented past history or fulfilled the criteria of WHO 1999 |
| Previous stroke | Documented past history |
| Chronic kidney disease | Documented past history or fulfilled the criteria of KDIGO 2012 |
| COPD | Long-term use of bronchodilators or steroids for lung disease |
| ALT | - |
| EGFR | Estimated by the Modification of Diet in Renal Disease (MDRD) equation |
| NYHA III or IV | NYHA classification |
| Hypertension | Documented past history or SBP>140 mmHg and/or DBP > 90 mmHg |
| Coronary artery disease | Documented past history |
| Atrial fibrillation | Documented past history |
| Previous cardiovascular surgery | 1 or more previous major cardiac operation involving opening the pericardium |
| Previous TEVAR | Documented past history |
| Instable hemodynamics | Need for catecholamines at referral |
| LVEDD | - |
| Ejection fraction | - |
| Severe aortic regurgitation | - |
| Hydropericardium | Massive pericardiac fluid |
| Severely compressed true lumenin descending aorta | Revealed by CTA |
| Persistent abdominal pain | Persistent severe abdominal pain associated with aortic dissection |
| Lower limb ischemia | Symptoms or signs of lower limb ischemia, such as pain, numbness, or weak pulse of dorsal foot artery etc. |
| Clinical coronary ostium involved | The coronary ostium lesion confirmed in operation |
| Carotid ostium involved | Carotid ostium lesion confirmed in operation |
| Radiological celiac trunk malperfusion | Celiac trunk malperfusion revealed by CTA |
| Radiological superior mesenteric artery malperfusion | Superior mesenteric artery malperfusion revealed by CTA |
| Renal malperfusion | Unilateral or bilateral renal malperfusion revealed by CTA, regardless of renal function |
| Radiological iliac-femoral malperfusion | Unilateral or bilateral iliac-femoral malperfusion revealed by CTA |
| Concomitant with aortic root surgery | Combined with bentall or valve sparing root replacement surgery |
| CABG | Combined with CABG surgery |
| Salvage CABG | The CABG was not planned preoperatively, and was performed because a post-operative hemodynamic instability (such as malignant arrhythmia or failing to wean from cardiopulmonary bypass) occurred with suspicion of myocardial ischemia |
| Carotid bypass | Combined with uni- or bilateral carotid bypass surgery. |
| CPB time > 4 h | - |
| DHCA temperature | Nasopharyngeal temperature |
| DHCA time | - |
| 30-day postoperative deaths | All-cause mortality |
BMI, body mass index; WHO, world health organization; KDIGO, kidney disease, improving global outcomes; COPD, chronic obstructive pulmonary disease; ALT, Alanine Aminotransferase; EGFR, estimated glomerular filtration rate; NYHA, New York heart association; SBP, systolic blood pressure; DBP, diastolic blood pressure; TEVAR, thoracic endovascular aortic repair; TTE, transthoracic echocardiography; LVEDD, left ventricular end-diastolic diameter; CTA, computed tomographic angiography; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; DHCA, deep hypothermia and circulatory arrest.
Multivariable analysis of perioperative parameters.
|
|
|
|
|
|
|---|---|---|---|---|
| LVEDD <45 mm | 1.0128 | 0.314 | 3.225 | 0.001** |
| EGFR <50 ml/min/1.73m2 | 0.8983 | 0.4127 | 2.177 | 0.03* |
| Persistent abdominal pain | 2.174 | 0.6318 | 3.441 | <0.001*** |
| Previous stroke | 0.6512 | 0.5279 | 1.234 | 0.217 |
| Clinical coronary ostium lesion | 0.3637 | 0.5054 | 0.72 | 0.472 |
| Radiological celiac trunk malperfusion | 0.8631 | 0.3553 | 2.429 | 0.015* |
| CABG | 0.8535 | 0.3122 | 2.734 | 0.006** |
| CPB time > 4 h | 1.4003 | 0.2897 | 4.833 | <0.001*** |
| Age | 0.014 | 0.0137 | 1.022 | 0.307 |
| Intercept | −3.7806 | 0.2173 | −17.4 |
SE, standard error; LVEDD, left ventricular end-diastolic diameter; EGFR, estimated glomerular filtration rate; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass. *0.01 ≤ p < 0.05; **0.001 ≤ p < 0.05; ***p < 0.001.
Figure 3(A) Calibration curve of Nomogram in training cohort. (B) Calibration curve of Nomogram in testing cohort.
Figure 4(A) ROC curve of Nomogram in training cohort. (B) ROC curve of Nomogram in testing cohort.
Figure 5Brier scores of Nomogram and the other 4 machine learning models in testing cohort.
Figure 6AUCs of Nomogram and the other 4 machine learning models in testing cohort.